New diabetes treatment: Rybelsus
The US Food and Drug Administration (FDA) has just approved a new drug for diabetes, which was developed by Danish pharmaceutical company Novo Nordisk.
What does it consist of? It is an oral treatment for adult patients with type 1 diabetes, which helps control blood sugar.
How does Rybelsus work?
As miracles do not exist, this new treatment for type 1 diabetes must be accompanied by frequent exercise and a healthy and balanced diet.
It is the first treatment that does not require its application by means of syringes.
How should it be supplied?
Every day, thirty minutes before ingesting the first food or medicine of the day, the patient should take a paste with no more than 120 ml of plain water.
Consequences of using Rybelsus
1. So far a series of possible consequences are known; such as:
2. Slow digestive process.
3. It can inflame the pancreas.
4. Sickness.
5. Diarrhea.
6. Vomiting.
7. Decreases the urge to eat.
8. It generates constipation.
9. It could happen that the patient has a considerable drop in blood sugar.
10. Renal problems.
11. Hypersensitivity.
12. Possible risk of thyroid C cell tumors.
No more syringes or pumps?
No, although it is true that it turns out to be a great advance for those who suffer from diabetes; It is no less true that treatments that are already known cannot be substituted.
This is because this new drug known as Rybelsus does not work for all people, each case must be evaluated by a specialist, who will be in charge of determining what type of treatment the patient requires, or suddenly a fusion of treatments.
Is the use of Rybelsus recommended ?
Once several trials were carried out, it was determined that Rybelsus can be used as an independent alternative, to be applied in combination with the treatments that are already known.
These studies made it possible to show a relevant reduction in blood sugar.